Bruce Campbell (2)
TerrAscend Corp
TER-CN
TOP PICK
Sep 25, 2019
They're building up nicely in Canada and the U.S., which is unusual for a cannabis company to be on both sides of the border. They've been signing some good deals. Has a fine CEO with a good track record in pharma. (Analysts’ price target is $15.00)
They're building up nicely in Canada and the U.S., which is unusual for a cannabis company to be on both sides of the border. They've been signing some good deals. Has a fine CEO with a good track record in pharma. (Analysts’ price target is $15.00)